All content for HD Insights Podcast is the property of Huntington Study Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Interview series with the people working in Huntington's disease research and treatments
Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger
HD Insights Podcast
47 minutes
5 years ago
Episode 20 - KINECT-HD with Dr. Dietrich Haubenberger
Dr. Dietrich Haubenberger, Medical Director at Neurocrine Biosciences, joined the HD Insights Podcast to talk about his work on the KINECT-HD study and his career journey to this point. KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.
HD Insights Podcast
Interview series with the people working in Huntington's disease research and treatments